[go: up one dir, main page]

WO2003028698A3 - Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique - Google Patents

Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique Download PDF

Info

Publication number
WO2003028698A3
WO2003028698A3 PCT/EP2002/010743 EP0210743W WO03028698A3 WO 2003028698 A3 WO2003028698 A3 WO 2003028698A3 EP 0210743 W EP0210743 W EP 0210743W WO 03028698 A3 WO03028698 A3 WO 03028698A3
Authority
WO
WIPO (PCT)
Prior art keywords
active substance
pharmaceutical active
producing granulates
granulated material
granulates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/010743
Other languages
German (de)
English (en)
Other versions
WO2003028698A2 (fr
Inventor
Klaus-Juergen Steffens
Rudolf Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP02779415A priority Critical patent/EP1429735A2/fr
Priority to AU2002342755A priority patent/AU2002342755A1/en
Publication of WO2003028698A2 publication Critical patent/WO2003028698A2/fr
Publication of WO2003028698A3 publication Critical patent/WO2003028698A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un procédé de production de granules comprenant au moins un principe actif pharmaceutique. Selon ledit procédé, la poudre à mettre sous forme de granules est introduite dans une extrudeuse, réduite à l'état de masse de granulation par adjonction d'un liquide de granulation, ladite masse étant compactée grâce à l'application de forces de cisaillement. Un gaz ou un mélange gazeux peut éventuellement être introduit dans la masse de granulation compactée, afin de conférer de la porosité à la masse de granulation.
PCT/EP2002/010743 2001-09-26 2002-09-25 Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique Ceased WO2003028698A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02779415A EP1429735A2 (fr) 2001-09-26 2002-09-25 Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique
AU2002342755A AU2002342755A1 (en) 2001-09-26 2002-09-25 Method and device for producing granulates that comprise at least one pharmaceutical active substance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10147414.8 2001-09-26
DE10147414 2001-09-26

Publications (2)

Publication Number Publication Date
WO2003028698A2 WO2003028698A2 (fr) 2003-04-10
WO2003028698A3 true WO2003028698A3 (fr) 2003-10-23

Family

ID=7700318

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/010743 Ceased WO2003028698A2 (fr) 2001-09-26 2002-09-25 Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique

Country Status (3)

Country Link
EP (1) EP1429735A2 (fr)
AU (1) AU2002342755A1 (fr)
WO (1) WO2003028698A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834925B2 (en) 2006-08-25 2014-09-16 Purdue Pharma L.P. Tamper resistant dosage forms
US9161917B2 (en) 2008-05-09 2015-10-20 Grünenthal GmbH Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US20070098801A1 (en) * 2003-09-10 2007-05-03 Janssen Pharmaceutica N.V. Particles shaped as platelets
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
RU2493830C2 (ru) 2008-01-25 2013-09-27 Грюненталь Гмбх Лекарственная форма
KR20120050975A (ko) 2009-07-22 2012-05-21 그뤼넨탈 게엠베하 산화-민감성 오피오이드를 위한 내변조성 용량형
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
MX2013002377A (es) 2010-09-02 2013-04-29 Gruenenthal Gmbh Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
AR082862A1 (es) 2010-09-02 2013-01-16 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
PL2736495T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
CA2998259A1 (fr) 2015-09-10 2017-03-16 Grunenthal Gmbh Protection contre un surdosage par voie orale a l'aide de formulations a liberation immediate dissuasives d'abus
AR108302A1 (es) 2016-04-22 2018-08-08 Univ Mississippi Granulación en seco con doble husillo para producir formulaciones sólidas
DE102016218135A1 (de) * 2016-09-21 2018-03-22 Robert Bosch Gmbh Produktionsmodul zum Herstellen fester Arzneiformen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1629423A1 (de) * 1966-04-02 1971-01-14 Gruenzweig & Hartmann Verfahren zur Herstellung von Kunstharz-Schaumstoffen und Verwendung eines nach diesem Verfahren gefertigten Rohres
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
JPH07184550A (ja) * 1993-12-24 1995-07-25 Lotte Co Ltd 比重低減化チューインガムの製造方法
US5496865A (en) * 1993-12-08 1996-03-05 Brugg Kabel Ag Additive-charged porous carrier material

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1629423A1 (de) * 1966-04-02 1971-01-14 Gruenzweig & Hartmann Verfahren zur Herstellung von Kunstharz-Schaumstoffen und Verwendung eines nach diesem Verfahren gefertigten Rohres
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US5496865A (en) * 1993-12-08 1996-03-05 Brugg Kabel Ag Additive-charged porous carrier material
JPH07184550A (ja) * 1993-12-24 1995-07-25 Lotte Co Ltd 比重低減化チューインガムの製造方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1995, no. 10 30 November 1995 (1995-11-30) *
SCHROEDER R ET AL: "A new system for continuous wet granulation", PHARMAZEUTISCHE INDUSTRIE 2002 GERMANY, vol. 64, no. 3, 2002, pages 283 - 288, XP009012069, ISSN: 0031-711X *
See also references of EP1429735A2 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834925B2 (en) 2006-08-25 2014-09-16 Purdue Pharma L.P. Tamper resistant dosage forms
US8846086B2 (en) 2006-08-25 2014-09-30 Purdue Pharma L.P. Tamper resistant dosage forms
US8894988B2 (en) 2006-08-25 2014-11-25 Purdue Pharma L.P. Tamper resistant dosage forms
US8894987B2 (en) 2006-08-25 2014-11-25 William H. McKenna Tamper resistant dosage forms
US8911719B2 (en) 2006-08-25 2014-12-16 Purdue Pharma Lp Tamper resistant dosage forms
US9084816B2 (en) 2006-08-25 2015-07-21 Purdue Pharma L.P. Tamper resistant dosage forms
US9095615B2 (en) 2006-08-25 2015-08-04 Purdue Pharma L.P. Tamper resistant dosage forms
US9095614B2 (en) 2006-08-25 2015-08-04 Purdue Pharma L.P. Tamper resistant dosage forms
US9101661B2 (en) 2006-08-25 2015-08-11 Purdue Pharma L.P. Tamper resistant dosage forms
US9161917B2 (en) 2008-05-09 2015-10-20 Grünenthal GmbH Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet

Also Published As

Publication number Publication date
AU2002342755A1 (en) 2003-04-14
WO2003028698A2 (fr) 2003-04-10
EP1429735A2 (fr) 2004-06-23

Similar Documents

Publication Publication Date Title
WO2003028698A3 (fr) Procede et dispositif de production de granules comprenant au moins un principe actif pharmaceutique
Buffat Synthesis of piperidines
HUP0001329A3 (en) Densifyed granulate of substance enchancing disintegration for tablets, method for its producing and use
AU2003221365A1 (en) Porous material and process for producing the same
IL152024A0 (en) Pharmaceutical compositions containing thyroid hormone and processes for the manufacture thereof
WO2008144634A3 (fr) Remplissage d'unités de fenestration
AU2001295471A1 (en) Method for the continuous production of mixtures of substances and reaction mixtures and a device for carrying out said method
HUP0500832A3 (en) Pharmaceutical pellets comprising tamsulosin and process for making the same
AU2003220814A1 (en) Porous material and method for production thereof
EP1044687A4 (fr) Poudres contenant des trocotrienols, procede de production de ces poudres et comprimes prepares par moulage par compression de ces poudres
MXPA04006071A (es) Proceso para la produccion de tabletas de detergente.
AU2003213353A1 (en) Porous material and process for producing the same
AU6228699A (en) Process for producing spherical fine particles containing drug
CA2523807A1 (fr) Procede de fabrication de produits chimiques absorbants et formulations de produits chimiques absorbants
AU2001278538A1 (en) Method for encapsulating fine solid particles in the form of microcapsules
BR9912846B1 (pt) processo para fabricar um tablete de liberação controlada.
WO2005000237A3 (fr) Granules contenant des substances biologiquement actives
AU2001249393A1 (en) Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
CA2362761A1 (fr) Granulat pigmentaire pour la coloration de materiaux de construction et son procede de fabrication
GB0106469D0 (en) Solid formulation
AU5041501A (en) Moulding suitable for pharmaceutical applications and method for production thereof
MY120081A (en) Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
WO1999047543A3 (fr) Composition a liberation prolongee contenant un polymre amorphe
MXPA03004614A (es) Material estabilizado de crepado posterior y metodo para producir el mismo.
WO2005005936A8 (fr) Dispositif et procede de dosage

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002779415

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002779415

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP